Eli Lilly and Company (NYSE: LLY) announced today that it’s commenced a cash offer for up to $1.5 billion combined aggregate principal amount (the “Tender Cap”) of specified series of its outstanding debt securities. Pursuant to the offer , Lilly is offering to get , under certain conditions and subject to certain limitations, its 4.150% Notes due 2059 (the “4.150% Notes”), 3.950% Notes due 2049 (the “3.950% Notes”), 7.125% Notes due 2025 (the “7.125% Notes”), 6.770% Notes due 2036 (the “6.770% Notes”), 5.950% Notes due 2037 (the “5.950% Notes”), 5.550% Notes due 2037 (the “5.550% Notes”), 5.500% Notes due 2027 (the “5.500% Notes”), 4.650% Notes due 2044 (the “4.650% Notes”), 3.950% Notes due 2047 (the “3.950% Notes due 2047”), 3.875% Notes due 2039 (the “3.875% Notes”), 3.700% Notes due 2045 (the “3.700% Notes”), 3.375% Notes due 2029 (the “3.375% Notes”), 3.100% Notes due 2027 (the “3.100% Notes”), 2.750% Notes due 2025 (the “2.750% Notes”) and a couple of .350% Notes due 2022 (the “2.350% Notes”) (collectively, the “notes”).
The early tender date and time is 5:00 p.m., ny City time, on September 20, 2021, unless extended. The offer is scheduled to expire at 11:59 p.m., ny City time, on October 4, 2021, unless extended or earlier terminated. The terms, conditions and limitations of the offer are described within the Offer to get dated as of today’s date.
Holders of notes subject to the offer must validly tender and not validly withdraw their notes before the first tender date to be eligible to receive the entire consideration (as described below). Only holders that validly tender and don’t validly withdraw their notes on or before the first tender date are going to be eligible to receive the first tender premium (as described below). Tendered notes may only be withdrawn on or before 5:00 p.m., ny City time, on September 20, 2021. Notes tendered after the withdrawal date and before the expiration date might not be withdrawn, except in certain limited circumstances where additional withdrawal rights are required by law.
The table below sets forth certain information regarding the notes and therefore the offer .
View News Release Full Screen
Title of Security
CUSIP No.
Principal
Amount
Outstanding
Acceptance
Priority
Level
Reference U.S.
Treasury Security
Bloomberg
Reference
Page
Fixed Spread
Early
Tender
Premium(1)
4.150% Notes due 2059
532457 BU1
$1,000,000,000
1(2)
2.375% due May 15, 2051
FIT1
80 bps
$30
3.950% Notes due 2049
532457 BT4
$1,500,000,000
2(3)
2.375% due May 15, 2051
FIT1
70 bps
$30
7.125% Notes due 2025
532457 AM0
$229,692,000
3
0.750% due August 31, 2026
FIT1
15 bps
$30
6.770% Notes due 2036
532457 AP3
$174,445,000
4
1.250% due Assumption , 2031
FIT1
105 bps
$30
5.950% Notes due 2037
532457 BC1
$284,112,000
5
1.750% due Assumption , 2041
FIT1
55 bps
$30
5.550% Notes due 2037
532457 BA5
$476,152,000
6
1.750% due Assumption , 2041
FIT1
50 bps
$30
5.500% Notes due 2027
532457 AZ1
$377,505,000
7
0.750% due August 31, 2026
FIT1
40 bps
$30
4.650% Notes due 2044
532457 BG2
$43,016,000
8
1.750% due Assumption , 2041
FIT1
75 bps
$30
3.950% Notes due 2047
532457 BR8
$436,129,000
9
2.375% due May 15, 2051
FIT1
70 bps
$30
3.875% Notes due 2039
532457 BS6
$360,745,000
10
1.750% due Assumption , 2041
FIT1
45 bps
$30
3.700% Notes due 2045
532457 BJ6
$412,467,000
11
2.375% due May 15, 2051
FIT1
65 bps
$30
3.375% Notes due 2029
532457 BV9
$1,150,000,000
12
1.250% due Assumption , 2031
FIT1
15 bps
$30
3.100% Notes due 2027
532457 BP2
$401,450,000
13
0.750% due August 31, 2026
FIT1
35 bps
$30
2.750% Notes due 2025
532457 BH0
$560,646,000
14
0.750% due August 31, 2026
FIT1
0 bps
$30
2.350% Notes due 2022
532457 BQ0
$750,000,000
15
1.750% due May 15, 2022
FIT3
10 bps
$30
About Eli Lilly and Company
Lilly may be a global healthcare leader that unites caring with discovery to make medicines that make life better for people round the world. We were founded quite a century ago by a person committed to making high-quality medicines that meet real needs, and today we remain faithful that mission altogether our work. Across the world , Lilly employees work to get and convey life-changing medicines to those that need them, improve the understanding and management of disease, and provides back to communities through philanthropy and volunteerism. F-LLY
Source link: http://lilly.mediaroom.com/
